HopeStage
Back to all studies
TerminatedNCT00352768

Fluvoxamine Maleate in the Treatment of OCD: A Post-marketing Clinical Study in Children and Adolescents

Researchers are comparing Fluvoxamine maleate and placebo to find out how the approaches affect obsessive thoughts and compulsive behaviours in children and adolescents with OCD.

Medication studyAges 8–18Japan
The study in practice

Understand this study

What is this study about?

Researchers are comparing Fluvoxamine maleate and placebo to find out how the approaches affect obsessive thoughts and compulsive behaviours in children and adolescents with OCD.

Who could participate?

This study is for people with OCD. Listed age limits: 8 years to 18 years. Other eligibility criteria apply.

Listed locations
Chiba Prefecture and 10 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateAugust 2006
Recruitment status
Terminated
Enrollment listed in the registry
20
Sponsor
Solvay Pharmaceuticals
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Japan
Age range
From 8 Years to 18 Years
Official registry ID
NCT00352768
Official title
Show the full official title

SME3110 (Fluvoxamine Maleate) in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents (8 Through 18 Years of Age) -A Double-blind, Randomized, Placebo-controlled Study

Recruitment & locations

Terminated

Chiba Prefecture · Fukuoka Prefecture · Hiroshima Prefecture

7 more locations
  • Hokkaido Prefecture
  • Hyogo Prefecture
  • Kagawa Prefecture
  • Kumamoto Prefecture
  • Mie Prefecuture
  • Nara Prefecture
  • Tokushima Prefecture

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

Researchers are comparing Fluvoxamine maleate and placebo to find out how the approaches affect obsessive thoughts and compulsive behaviours in children and adolescents with OCD.

Who is behind this study?

The study sponsor is Solvay Pharmaceuticals.

Does this study involve medication?

Yes. The study involves medication, including Fluvoxamine maleate and Placebo.

Who can participate?

This study is for people with OCD. Listed age limits: 8 years to 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies